These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3446165)

  • 1. Usefulness of estimating individual pharmacokinetic data for aminoglycoside therapy in seriously ill patients.
    Denaro CP; Ravenscroft PJ
    Aust N Z J Med; 1987 Oct; 17(5):526-32. PubMed ID: 3446165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.
    Barletta JF; Johnson SB; Nix DE; Nix LC; Erstad BL
    J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized aminoglycoside dosage regimens in patients with cystic fibrosis.
    Delage G; Desautels L; Legault S; Lasalle R; Lapierre JG; Lamarre A; Masson P; Spier S
    Drug Intell Clin Pharm; 1988 May; 22(5):386-9. PubMed ID: 3391108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients.
    Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB
    Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries.
    Hoey LL; Tschida SJ; Rotschafer JC; Guay DR; Vance-Bryan K
    J Burn Care Rehabil; 1997; 18(2):116-24. PubMed ID: 9095420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Sawchuk-Zaske and Bayesian forecasting for aminoglycosides in seriously ill patients.
    Denaro CP; Ravenscroft PJ
    Br J Clin Pharmacol; 1989 Jul; 28(1):37-44. PubMed ID: 2775614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.
    Koo J; Tight R; Rajkumar V; Hawa Z
    Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of optimal prophylactic aminoglycoside dosage in cancer patients: population pharmacokinetic approaches.
    Ordovás JP; Ronchera CL; Poveda JL; Jiménez NV; López R
    J Clin Pharm Ther; 1994 Feb; 19(1):47-56. PubMed ID: 8188791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis.
    Alghanem S; Paterson I; Touw DJ; Thomson AH
    J Antimicrob Chemother; 2013 Jun; 68(6):1338-47. PubMed ID: 23435691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An approach to forecast aminoglycoside-related nephrotoxicity from routinely collected clinical data.
    Kubota K; Suganuma T; Sasaki T; Ishizaki T
    Ther Drug Monit; 1988; 10(4):410-20. PubMed ID: 3201525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded gentamicin volume of distribution in critically ill adult patients receiving total parenteral nutrition.
    Ronchera-Oms CL; Tormo C; Ordovás JP; Abad J; Jiménez NV
    J Clin Pharm Ther; 1995 Oct; 20(5):253-8. PubMed ID: 8576291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations.
    Conil JM; Georges B; Ruiz S; Rival T; Seguin T; Cougot P; Fourcade O; Pharmd GH; Saivin S
    Br J Clin Pharmacol; 2011 Jan; 71(1):61-71. PubMed ID: 21143502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
    Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA
    Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.
    Matthews I; Kirkpatrick C; Holford N
    Br J Clin Pharmacol; 2004 Jul; 58(1):8-19. PubMed ID: 15206987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobramycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single daily dosing of gentamicin: pharmacokinetic comparison of two dosing methodologies for postpartum endometritis.
    Liu C; Abate B; Reyes M; Gonik B
    Infect Dis Obstet Gynecol; 1999; 7(3):133-7. PubMed ID: 10371471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycoside monitoring program.
    Vakoutis J; Stein GE; Miller PB; Clayman AE
    Am J Hosp Pharm; 1981 Oct; 38(10):1477-80. PubMed ID: 7294041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.